Regulatory Review Of Promotional Materials For An EU-Based Pharmaceutical Company Across 60+ Global Markets
By Reham Alassily (Middle East), Chikkam Rama Mohan Rao (APAC), Malgorzata Sypniewska (UK, Ireland), Joanna Szmidt (Poland)

The regulatory landscape governing pharmaceutical promotional and non-promotional materials poses a significant challenge, especially for pharmaceutical companies with a global presence.
One such company was dedicated to ensuring compliance with a multitude of regulations in the European Union, as well as national regulations in various countries, including emerging markets in the Asia-Pacific (APAC), Latin America (LATAM), and the Middle East. This ambitious endeavor encompassed over 2,000 promotional and non-promotional materials distributed across 60 different countries.
The company was in search of a comprehensive, scalable, and cost-effective solution to navigate the intricate web of international regulations, cater to diverse market requirements, and effectively coordinate with multiple vendors. IQVIA stepped in to provide support across a wide spectrum of materials, including sales aids, brochures, website content, social media posts, press releases, medical education resources, journal articles, direct-to-consumer advertising, scientific presentations, posters, and patient education materials.
Unearth IQVIA's strategy for overcoming these hurdles and how the company completed a successful regulatory review of promotional and non-promotional materials across diverse global markets.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.